Provided by Tiger Fintech (Singapore) Pte. Ltd.

LiveRamp Holdings, Inc.

31.36
+0.89002.92%
Post-market: 31.360.00000.00%18:51 EDT
Volume:451.75K
Turnover:14.06M
Market Cap:2.04B
PE:-2.17K
High:31.40
Open:30.46
Low:30.12
Close:30.47
Loading ...

Liveramp Holdings Inc Outlook FY25 Revenue $741 Mln - $743 Mln

THOMSON REUTERS
·
06 Feb

Liveramp Holdings Inc Q3 Shr View $0.41 -- Lseg Ibes Data

THOMSON REUTERS
·
06 Feb

Liveramp Holdings Inc Qtrly Adj EPS $0.55

THOMSON REUTERS
·
06 Feb

LiveRamp Holdings Q3 Adj $0.55 Beats $0.46 Estimate, Sales $195.41M Beat $190.98M Estimate

Benzinga
·
06 Feb

BRIEF-LiveRamp Q3 Revenue USD 195 Million

Reuters
·
06 Feb

Liveramp Q3 Adjusted Gross Margin 74%

THOMSON REUTERS
·
06 Feb

LiveRamp Holdings Price Target Maintained With a $42.00/Share by Benchmark

Dow Jones
·
04 Feb

LiveRamp (RAMP) Reports Earnings Tomorrow: What To Expect

StockStory
·
04 Feb

Craig-Hallum Sticks to Its Buy Rating for LiveRamp Holdings (RAMP)

TIPRANKS
·
03 Feb

LiveRamp to Discuss Third Quarter Financial Results

GlobeNewswire
·
23 Jan

LiveRamp to Host Investor Day on February 25, 2025

GlobeNewswire
·
17 Jan

LiveRamp and Mohegan Launch Industry’s First Casino Media Network

Business Wire
·
14 Jan

LiveRamp Holdings Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
13 Jan

Morgan Stanley Downgrades LiveRamp to Equal Weight From Overweight

MT Newswires Live
·
13 Jan

System1 Receives Notice of Non-Compliance with New York Stock Exchange Trading Share Price Listing Rule

Business Wire
·
11 Jan

Macquarie Remains a Buy on LiveRamp Holdings (RAMP)

TIPRANKS
·
19 Dec 2024

System1 to Participate in the 2025 ICR Conference and 27th Annual Needham Growth Conference

Business Wire
·
18 Dec 2024

Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Business Wire
·
18 Dec 2024